作者: David Felmingham , Soichi Arakawa
DOI: 10.2165/00044011-200121001-00002
关键词: Trimethoprim 、 Antibiotic resistance 、 Ampicillin 、 Medicine 、 Environmental health 、 Ciprofloxacin 、 Cephalosporin 、 Sulfamethoxazole 、 Amoxicillin 、 Pediatrics 、 Pharmacotherapy
摘要: Comparison of bacterial resistance rates across different countries (e.g. in Europe) is difficult because variation laboratory methodology and interpretation results. Although urinary tract infection one the most common reasons for adults to seek medical consultation, data regarding among isolates are limited often reports based on results from a single centre. However, certain trends outside USA becoming evident. Reported amoxicillin or ampicillin Escherichia coli strains responsible infections approaching 50% UK, 30% Finland, 40% Germany France, 70% Spain. Resistance trimethoprim cotrimoxazole (trimethoprim/sulfamethoxazole) have been reported be region 20% Finland >40% fluoroquinolones has In Japan, MIC80 values representative fluoroquinolones, fourth-generation cephalosporins carbapenems against E. isolated outpatients increased over 3-year period. Rates aminopenicillins very high Latin America, >10% ciprofloxacin some recent years. Ongoing monitoring vital. Cooperative efforts will identify experience country may help another.